Sergio Siragusa

4.0k total citations
150 papers, 2.1k citations indexed

About

Sergio Siragusa is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Sergio Siragusa has authored 150 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 61 papers in Genetics and 31 papers in Internal Medicine. Recurrent topics in Sergio Siragusa's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (39 papers), Venous Thromboembolism Diagnosis and Management (31 papers) and Platelet Disorders and Treatments (27 papers). Sergio Siragusa is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (39 papers), Venous Thromboembolism Diagnosis and Management (31 papers) and Platelet Disorders and Treatments (27 papers). Sergio Siragusa collaborates with scholars based in Italy, United States and Spain. Sergio Siragusa's co-authors include Mariasanta Napolitano, Benilde Cosmi, Guglielmo Mariani, Jeffrey S. Ginsberg, Jack Hirsh, Franco Piovella, Salvatrice Mancuso, Marco Santoro, Melania Carlisi and Alessandra Malato and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Sergio Siragusa

138 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Siragusa Italy 26 960 748 595 470 360 150 2.1k
Laura Russo Italy 22 575 0.6× 652 0.9× 350 0.6× 464 1.0× 213 0.6× 56 1.7k
Ansgar Weltermann Austria 24 1.7k 1.8× 1.5k 2.1× 975 1.6× 424 0.9× 378 1.1× 69 2.9k
José Mateo Spain 26 1.5k 1.6× 930 1.2× 654 1.1× 399 0.8× 343 1.0× 100 2.5k
B. Kemkes‐Matthes Germany 23 897 0.9× 865 1.2× 642 1.1× 224 0.5× 830 2.3× 78 2.1k
Eduardo Rocha Spain 27 757 0.8× 688 0.9× 584 1.0× 143 0.3× 440 1.2× 108 2.0k
Sabrina Gavasso Italy 30 1.4k 1.4× 822 1.1× 463 0.8× 333 0.7× 327 0.9× 70 2.5k
Rainer Vormittag Austria 20 970 1.0× 1.7k 2.3× 947 1.6× 192 0.4× 336 0.9× 37 2.5k
David J. Kuter United States 20 926 1.0× 323 0.4× 216 0.4× 260 0.6× 445 1.2× 50 1.8k
Marina Marchetti Italy 34 1.6k 1.6× 939 1.3× 450 0.8× 1.5k 3.1× 286 0.8× 100 3.6k
Jeannine Kassis Canada 25 756 0.8× 1.5k 2.1× 868 1.5× 144 0.3× 885 2.5× 64 2.6k

Countries citing papers authored by Sergio Siragusa

Since Specialization
Citations

This map shows the geographic impact of Sergio Siragusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Siragusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Siragusa more than expected).

Fields of papers citing papers by Sergio Siragusa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Siragusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Siragusa. The network helps show where Sergio Siragusa may publish in the future.

Co-authorship network of co-authors of Sergio Siragusa

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Siragusa. A scholar is included among the top collaborators of Sergio Siragusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Siragusa. Sergio Siragusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madaudo, Cristina, Daniela Di Lisi, Antonio Cannatà, et al.. (2025). Cardiovascular Toxicity Induced by TKIs in Patients with Chronic Myeloid Leukaemia: Are Women and Men Different?. ESC Heart Failure. 12(2). 1447–1454. 1 indexed citations
2.
Barreca, Maria Magdalena, Stefania Raimondo, Alice Conigliaro, et al.. (2024). The Combination of Natural Compounds Escin–Bromelain–Ginkgo Biloba–Sage Miltiorrhiza (EBGS) Reduces Platelet Adhesion to TNFα-Activated Vascular Endothelium through FAK Signaling. International Journal of Molecular Sciences. 25(17). 9252–9252. 3 indexed citations
3.
Castaman, Giancarlo, Giovanni Di Minno, Paolo Simioni, et al.. (2024). Gene therapy for people with hemophilia B: a proposed care delivery model in Italy. Journal of Thrombosis and Haemostasis. 22(11). 3084–3096. 3 indexed citations
4.
Carlisi, Melania, et al.. (2024). Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma. Scientific Reports. 14(1). 2832–2832. 5 indexed citations
5.
Carlisi, Melania, Rosalia Lo Presti, Salvatrice Mancuso, Sergio Siragusa, & Gregorio Caimi. (2024). Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma. Clinical and Applied Thrombosis/Hemostasis. 30. 2995403981–2995403981. 1 indexed citations
6.
Carlisi, Melania, Rosalia Lo Presti, Salvatrice Mancuso, Sergio Siragusa, & Gregorio Caimi. (2023). Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors. Biomedicines. 11(3). 964–964. 2 indexed citations
7.
Napolitano, Mariasanta & Sergio Siragusa. (2023). The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis. Cancers. 15(18). 4640–4640.
8.
Corsale, Anna Maria, Nadia Caccamo, Serena Meraviglia, et al.. (2023). Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome. International Journal of Molecular Sciences. 24(10). 8852–8852. 6 indexed citations
9.
Corsale, Anna Maria, Melania Carlisi, Nadia Caccamo, et al.. (2023). Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again. SHILAP Revista de lepidopterología. 15(1). 23–49. 2 indexed citations
10.
Castaman, Giancarlo, Christian Carulli, Raimondo De Cristofaro, et al.. (2022). Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study. Haemophilia. 29(2). 435–444. 5 indexed citations
11.
Mancuso, Salvatrice, et al.. (2022). Host‐related factors and cancer: Malnutrition and non‐Hodgkin lymphoma. Hematological Oncology. 40(3). 320–331. 14 indexed citations
12.
Lisi, Daniela Di, et al.. (2022). The New HFA/ICOS Risk Assessment Tool to Identify Patients with Chronic Myeloid Leukaemia at High Risk of Cardiotoxicity. ESC Heart Failure. 9(3). 1914–1919. 25 indexed citations
13.
Carlisi, Melania, Salvatrice Mancuso, Rosalia Lo Presti, et al.. (2021). Erythrocyte deformability in a group of Monoclonal Gammopathy of Undetermined Significance (MGUS) subjects. Preliminary analysis. 1 indexed citations
14.
Carlisi, Melania, Salvatrice Mancuso, Rosalia Lo Presti, Sergio Siragusa, & Gregorio Caimi. (2021). Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey. Clinical Hemorheology and Microcirculation. 79(3). 475–483. 4 indexed citations
15.
Napolitano, Mariasanta, et al.. (2020). <p>Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey</p>. Patient Preference and Adherence. Volume 14. 1145–1147. 4 indexed citations
16.
Raimondo, Stefania, Ornella Urzì, Alice Conigliaro, et al.. (2020). Extracellular Vesicle microRNAs Contribute to the Osteogenic Inhibition of Mesenchymal Stem Cells in Multiple Myeloma. Cancers. 12(2). 449–449. 50 indexed citations
17.
Santoro, Marco, Vincenzo Accurso, Salvatrice Mancuso, et al.. (2019). Comparison between thrombotic risk scores in essential thrombocythemia and survival implications. Hematological Oncology. 37(4). 434–437. 10 indexed citations
18.
Zanon, Ezio, Samantha Pasca, Elena Santagostino, et al.. (2019). Immune tolerance induction with moroctocog‐alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high‐titre inhibitors: Data from REF.IT Registry. Haemophilia. 25(6). 1003–1010. 2 indexed citations
19.
Mancuso, Salvatrice, Melania Carlisi, Mariasanta Napolitano, & Sergio Siragusa. (2018). Lymphomas and thyroid: Bridging the gap. Hematological Oncology. 36(3). 519–524. 10 indexed citations
20.
Mariani, Guglielmo, Alberto Dolce, Angelika Bátorová, et al.. (2010). Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STER. British Journal of Haematology. 152(3). 340–346. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026